Verburg FA - Search Results

1

Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level.

Hänscheid H, Verburg FA, Biko J, Diessl S, Demidchik YE, Drozd V, Reiners C. Hänscheid H, et al. Among authors: verburg fa. Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1296-302. doi: 10.1007/s00259-011-1788-y. Epub 2011 Apr 2. Eur J Nucl Med Mol Imaging. 2011. PMID: 21461735

2

Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients.

Verburg FA, de Keizer B, Lips CJ, Zelissen PM, de Klerk JM. Verburg FA, et al. Eur J Endocrinol. 2005 Jan;152(1):33-7. doi: 10.1530/eje.1.01819. Eur J Endocrinol. 2005. PMID: 15762184

3

Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablation.

Verburg FA, de Keizer B, Lam MG, de Klerk JM, Lips CJ, Borel-Rinkes IH, van Isselt JW. Verburg FA, et al. World J Surg. 2007 Dec;31(12):2309-14. doi: 10.1007/s00268-007-9257-2. World J Surg. 2007. PMID: 17952702

4

The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies.

Verkooijen RB, Verburg FA, van Isselt JW, Lips CJ, Smit JW, Stokkel MP. Verkooijen RB, et al. Among authors: verburg fa. Eur J Endocrinol. 2008 Sep;159(3):301-7. doi: 10.1530/EJE-08-0062. Epub 2008 Jun 20. Eur J Endocrinol. 2008. PMID: 18567668 Clinical Trial.

5

Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma.

Verburg FA, Dietlein M, Lassmann M, Luster M, Reiners C. Verburg FA, et al. Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):343-6. doi: 10.1007/s00259-008-0997-5. Eur J Nucl Med Mol Imaging. 2009. PMID: 19050874 Review. No abstract available.

6

Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma.

Verburg FA, Mäder U, Luster M, Reiners C. Verburg FA, et al. Clin Endocrinol (Oxf). 2009 Aug;71(2):291-7. doi: 10.1111/j.1365-2265.2008.03482.x. Epub 2008 Dec 3. Clin Endocrinol (Oxf). 2009. PMID: 19067727

7

Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.

Verburg FA, Mäder U, Luster M, Reiners C. Verburg FA, et al. Eur J Endocrinol. 2009 Apr;160(4):619-24. doi: 10.1530/EJE-08-0805. Epub 2009 Jan 21. Eur J Endocrinol. 2009. PMID: 19158232

8

Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults.

Doyle P, Düren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C, Luster M. Doyle P, et al. Among authors: verburg fa. J Clin Endocrinol Metab. 2009 Aug;94(8):2970-4. doi: 10.1210/jc.2008-2403. Epub 2009 Jun 2. J Clin Endocrinol Metab. 2009. PMID: 19491231

9

Intratracheal growth of recurrent benign goiter.

Verburg FA, Gasser M, Beissert M, Geissinger E, Luster M, Reiners C. Verburg FA, et al. Thyroid. 2009 Sep;19(9):1009-11. doi: 10.1089/thy.2009.0067. Thyroid. 2009. PMID: 19731981

10

Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.

Luster M, Handkiewicz-Junak D, Grossi A, Zacharin M, Taïeb D, Cruz O, Hitzel A, Casas JA, Mäder U, Dottorini ME; Pediatric rhTSH Investigators Group. Luster M, et al. J Clin Endocrinol Metab. 2009 Oct;94(10):3948-53. doi: 10.1210/jc.2009-0593. Epub 2009 Sep 22. J Clin Endocrinol Metab. 2009. PMID: 19773393

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters